Growth Hormone Deficiency in Pediatric Patients

What Is Growth Hormone Deficiency in Pediatric Patients?

Insufficient production of growth hormone (GH) by the pituitary gland results in growth hormone insufficiency. The growth of bones and other tissues is stimulated by growth hormone (GH). One can get this condition at any age. A child's IQ is unaffected by GH deficiency.

A deficiency of one or more anterior pituitary hormones, such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH), and thyroid-stimulating hormone (TSH), as well as vasopressin (antidiuretic hormone [ADH]), which is produced in the hypothalamus and stored in the posterior pituitary, is also present in patients with growth hormone deficiency associated with generalized hypopituitarism (panhypopituitarism).

Primary hypopituitarism is a pituitary illness, whereas secondary hypopituitarism results from disruption of certain releasing hormones' hypothalamic secretion, which regulates anterior pituitary hormone synthesis (GH, FSH, LH, ACTH, and TSH).

What Are the Causes of Growth Hormone Deficiency in Pediatric Patients?

These are a few of the causes of growth hormone deficiency in pediatric patients:

• Trauma: Damage to the pituitary gland or the hypothalamus, another gland, may be the cause of growth hormone insufficiency. The injury may be acquired or occur during or after delivery, or it may occur before birth (congenital). At the base of the brain sits a gland the size of a pea called the pituitary. It is the body's principal endocrine gland. Up to eight distinct hormones are typically released by the pituitary gland. These hormones regulate blood pressure, growth, metabolism, and other bodily functions. Rarely, GH insufficiency may be a component of a hereditary condition.
• Isolated Growth Hormone Insufficiency: The estimated incidence of isolated growth hormone insufficiency in children is 1/4,000 to 1/10,000. Although roughly 25 percent of patients have a known cause, it is mostly idiopathic. Congenital causes include various deformities of the central nervous system (CNS) and anomalies of the GH1 gene and GH-releasing hormone receptor. Meningitis, histiocytosis, brain damage, and therapeutic radiation of the central nervous system (large doses of radiation can cause generalized hypopituitarism) are examples of acquired causes. Prophylactic or therapeutic radiation to the spine may further reduce the vertebrae's capacity to grow and jeopardize height gain.
• Generalized Hypothyroidism: Hereditary or spontaneous mutations affecting pituitary cells could be the cause of generalized hypopituitarism. Anomalies of various organ systems, especially midline deformities like cleft palate or septo-optic dysplasia (which includes hypopituitarism, optic nerve atrophy, and lack of the septum pellucidum), may also exist in such cases. Infections (such as tuberculosis, toxoplasmosis, and meningitis), tumors (such as craniopharyngiomas, which are most common), and infiltrative disorders can all cause generalized hypopituitarism by impairing the hypothalamus's ability to secrete hormones. Diabetes insipidus, a condition marked by arginine vasopressin insufficiency and lytic lesions of the bones or skull, indicates Langerhans cell histiocytosis.

Which Children Are at Risk for Growth Hormone Deficiency?

Any of the following increases a child's likelihood of developing GH deficiency:

• Brain damage.
• Brain tumor.
• Head-related radiation therapy.

All of the risk factors are absent in some children with the issue.

What Are the Symptoms of Growth Hormone Deficiency in Pediatric Patients?

After a kid turns three, the primary indicator of growth hormone insufficiency is a modest annual increase in height. This indicates a height gain of less than 3.5 centimeters, or 1.4 inches, every year. Growth hormone (GH) shortage in children can also result in:

• A face that seemed younger.
• A plump physique.
• Reduced development of hair.
• Delayed adolescence.

It is crucial to remember that growth hormone (GH) insufficiency has no bearing on a child's intelligence. Growth hormone (GH) deficiency symptoms can resemble those of other medical disorders. Ensure that the child visits the doctor to receive a diagnosis.

How Is Growth Hormone Deficiency in Pediatric Patients Diagnosed?

The medical professional treating the child must rule out other illnesses to identify GH insufficiency, including:

• Normal growth variances, such as short stature in the family.
• Other conditions include kidney illness or a thyroid hormone shortage.
• Genetic conditions.

The medical professional will inquire about the symptoms, medical history, and family medical history of the child. Additionally, he or she will examine the youngster physically. Over several months, the health and development of the child may be monitored. Additionally, the child might take tests like:

• Blood Tests: These are performed to measure the levels of growth hormone and other associated hormones. Occasionally, the child's blood tests are conducted following the administration of a medication that typically elevates growth hormone levels.
• X-Ray: This test creates images of internal body tissues by using a tiny quantity of radiation. An X-ray of the left wrist and hand may be performed. This can determine the age of the child's bones. In cases of hormone imbalances or delayed puberty, bone age is frequently lower than chronological age.
• Computed Tomography Scan: This test creates detailed images of the body by using a succession of X-rays and a computer. Organs, fat, muscles, and bones can all be seen on a CT scan. Compared to standard X-rays, CT scans provide more detail.
• MRI: This test creates finely detailed images of bodily tissues using big magnets and a computer.
• Auxologic evaluation (statistics on weight and height on a growth chart).
• Levels of IGF-binding protein type 3 (IGFBP-3) and insulin-like growth factor 1 (IGF-1).

How Is Growth Hormone Insufficiency in Pediatric Patients Treated?

The treatment options are:

• Replacements with recombinant GH.
• Restoration of pituitary hormones on occasion.

The doctor treating the kid will take into account several factors, including age and general health, before recommending a course of treatment. A pediatric endocrinologist may be necessary for the child's care. This physician has received further training in managing hormone-related issues in children. Additionally, this professional will be equipped with the greatest tools to measure the child's growth month after month.

Daily infusions of synthetic growth hormone by injection are used as a treatment. It is common to observe results three to four months following the start of treatment. Usually, the treatment lasts for several years, or until late adolescence, when growth is completed. A child's chances of having an adult height that reflects his or her family pattern—normal or nearly normal—are better the earlier the treatment is initiated.

Not every child reacts favorably to growth hormone therapy. A person receiving GH therapy will not grow taller than their parents.

In What Ways May a Child With GH Deficiency Be Supported?

Youngsters who are smaller than their classmates may experience sadness or low self-esteem. It is crucial to discuss these issues with both the child's doctor and oneself. He or she can suggest organizations for support or counseling for both the parent and the child.

Discuss the child's possible adult height with their healthcare professional. To manage the child's condition over time, collaborate with their medical professionals.

Conclusion:

GH deficiency can happen by itself in conjunction with generalized hypopituitarism. Congenital (including hereditary) diseases and some acquired abnormalities of the pituitary and hypothalamus are among the causes. Short stature results from GH deficiency; additional symptoms may also exist, depending on the underlying cause. Clinical observations, imaging examinations, and laboratory testing—typically involving provocative tests of growth hormone production—are used to make the diagnosis. GH should be administered to children who are small in stature and have a verified GH shortage; additional hypopituitarism symptoms should be addressed as needed.